key: cord-0985464-wb6kwgiq authors: Kovačević, Milena; Ćulafić, Milica; Vezmar Kovačević, Sandra; Borjanić, Slavenka; Keleč, Branka; Miljković, Branislava; Amidžić, Rada title: Telepharmacy service experience during the COVID‐19 pandemic in the Republic of Srpska, Bosnia and Herzegovina date: 2021-09-28 journal: Health Soc Care Community DOI: 10.1111/hsc.13590 sha: a9ebda562d451b331b5e9123b6ea1c2ca94eb876 doc_id: 985464 cord_uid: wb6kwgiq The COVID‐19 pandemic exerted a profound impact on health systems worldwide. Moreover, significant concerns were raised in terms of middle‐ and long‐term consequences of postponing care in non‐COVID patients. The primary aim of the study was to describe the remote pharmaceutical care service (telepharmacy) during the COVID‐19 pandemic in the Republic of Srpska (RS), Bosnia and Herzegovina. The secondary aim was to identify service users’ needs and concerns and to describe community pharmacists’ interventions. Ten community pharmacists were appointed by the Pharmaceutical Society of the RS to deliver telepharmacy services. After obtaining users’ verbal permission, pharmacists documented issues discussed with them. The prospective data collection included the period from April 13 to May 21, 2020. Descriptive and statistical analysis was performed using IBM SPSS Statistics software (ver. 22). A total of 71 service users’ charts were analyzed. Telepharmacy users were on average 61.31 ± 13.27 years of age, with almost equal gender distribution. Patients with chronic or acute/subacute conditions were predominant with a share of 84.5%. Chronic diseases were the main reason for searching pharmacists’ consultation (74.6%), 7% had a complaint about worsening of a chronic condition, 9.9% reported only acute/subacute conditions as ambulatory conditions, whereas 15.5% asked information about coronavirus or COVID‐19. The vast majority of patients’ and users’ needs were addressed by a pharmacist during counseling and only 15.5% of the patients required immediate referral to a doctor for refill/prescribing purposes. Remote pharmaceutical care service (telepharmacy) is deemed a convenient model in the RS during the COVID‐19 pandemic. Patients and users presented with explicit and specific needs and concerns, both COVID‐ and non‐COVID‐related, which should not be neglected. Community pharmacists showed a high level of resilience and ability in addressing patients' needs. The COVID-19 pandemic exerted a profound impact and burden on health systems worldwide. To ensure the healthcare system can cope with the surge in health needs because of the pandemic, the health response was split into two sections, COVID and non-COVID. Nevertheless, COVID-centres took the primate in healthcare resources utilisation, both in terms of human resources and medication supplies. Therefore, significant concerns were raised in terms of middle-and long-term consequences of postponing care in chronic non-COVID patients (Domeyer et al., 2020; Mauro et al., 2020) . There is a major concern that the suspension of caring for a chronic disease could cause a marked rise in hospital admissions and related healthcare costs, further increasing the burden on health systems irrespective of the chronic disease impact on COVID-19 outcomes (Domeyer et al., 2020; Yang et al., 2020) . In a recently published study, general practitioners reported a decrease in the number of regular consultations with chronic patients by 70%-80%, with similar findings observed for acute problems in European primary care settings (Verhoeven et al., 2020) . The observed decrease in physician-patient consultations could be explained by two main reasons: patient's fear of getting infected or physician's overload with respiratory symptoms assessment and triage (Verhoeven et al., 2020) . Community pharmacists are the most accessible healthcare professionals (Todd et al., 2014) , proving their indispensable role in health systems, both in regard to COVID-19 pandemic control and regular pharmaceutical care services to patients and users. Many studies have described new and emerging roles during the COVID-19 pandemic, as well as reassured community pharmacists' considerable impact on chronic disease management. The majority of recommendations for providing pharmaceutical care during the COVID-19 pandemic come from China; nevertheless, scientific publications also provide insight into the situation in the pharmacy sector in Macau, Nigeria, Saudi Arabia, United Arab Emirates, India, Ghana, Egypt, and Canada (Arain et al., 2021; Austin & Gregory, 2021; Bahlol & Dewey, 2021; Basu, 2020; Hedima et al., 2021; Ibrahim et al., 2020; Kretchy et al., 2021; Li et al., 2021; Liu et al., 2020; Meghana et al., 2021; Mohamed Ibrahim et al., 2021; Ung, 2020; Zheng et al., 2021) . The increase of interest in research and publishing of pharmaceutical care services is driven by the urge of reflecting and defining pharmacists' roles to best respond to the pandemic outbreak which has no predictable end time. Moreover, the experience gained during this pandemic would be beneficial for pharmacy practice resilience in future emergencies (Austin & Gregory, 2021) . Merks et al. provided a detailed review of the legal extension of the pharmacists' role in light of the COVID-19 pandemic in European countries, Canada, and the United States (Merks et al., 2021) . The review summarised that many countries have facilitated remote pharmaceutical care services, such as Internet services, virtual medical consultations, e-prescriptions and home drug delivery, to promote social distancing between patients and healthcare providers (Merks et al., 2021) . Telepharmacy is defined as 'the provision of pharmaceutical care to patients at a distance, through the use of telecommunication and information technologies' (Casey et al., 2010; Win, 2017) . It was developed to serve patients in rural areas with healthcare shortages, and it reaches its maximum use in the time of pandemics (Le et al., 2020) . A large-scale study from the United Arab Emirates included 52 community pharmacies and demonstrated the capacity of telepharmacy to reduce the burden on the health care systems (Mohamed Ibrahim et al., 2021) . Besides policies overview, so far no results on telepharmacy experience were published from the European community pharmacy settings. The Republic of Srpska (RS) is one of the two constituent entities of Bosnia and Herzegovina, with an estimated population of ~1 million. Upon the declaration of a national emergency state in RS on March 28, 2020, different measures were employed ranging from restricting population movement and increasing social distancing to implementing voluntary or enforced isolation, similarly to most of the European countries (Fong et al., 2020) . At the beginning of the COVID-19 pandemic in RS, curfew measures were primarily directed to elderly chronic patients, as the most vulnerable part of the population (The National Assembly of the Republic of Srpska, 2020). In line with that, the local government office in collaboration with the Pharmaceutical Society of RS issued a public call toward community pharmacies on March 26 (The Pharmaceutical Society of the Republic of Srpska, 2020a). The planned activities were aimed to support elderly chronic disease patients and provide home drug delivery in the capital city Banja Luka, as a part of the national campaign 'You are not Alone'. Afterward, the Pharmaceutical Society of RS has widened its professional activities on April 10, providing the free counseling telephone helpline (The Pharmaceutical Society of the Republic of Srpska, 2020b). The campaign had wide media coverage, by national broadcasting service and on the internet. RS citizens were informed about the main goal of the free helpline-to provide access to professional and verified information and to minimise patients' visits to the pharmacy, by giving professional and • The COVID-19 pandemic exerted a profound impact and burden on health systems worldwide. • Significant concerns were raised in terms of middle-and long-term consequences of postponing care in chronic non-COVID patients. • Telepharmacy service study demonstrated that a heterogeneous group of patients and service users may benefit from remote pharmaceutical care activities. • Patients and users presented with explicit and specific needs and concerns, both COVID-and non-COVIDrelated, which should not be neglected. • Community pharmacists showed a high level of resilience and ability in addressing patients' needs. relevant information and advice on medications, self-medication, health promotion, dietary supplements and all other relevant health information. The helpline was not intended for advertising purposes, nor for providing information on drug prices. Since RS belongs to the southeastern European region, sharing policies on health system organisation with the surrounding countries, results derived from the RS community pharmacies may be useful for planning remote pharmaceutical care activities in other middle-income countries. The primary aim of the study was to describe the remote pharmaceutical care service (telepharmacy), firstly introduced in RS during the COVID-19 pandemic. The secondary aim was to identify service users' clinical and psychological needs and concerns during the pandemic and to describe ensuing community pharmacists' interventions, among the general population without constraints in terms of age or chronic diseases. Ten community pharmacists with experience in pharmaceutical care were appointed by the Pharmaceutical Society of RS to deliver remote pharmaceutical care (telepharmacy) activities from 8 a.m. to 8 p.m. Telepharmacy services were provided via telephone, by a centralised call number which was publicly advertised. The calls were redirected to the participating pharmacists (in total 7 community pharmacies) and this service was added in addition to their workload. Telepharmacy included the following services: providing relevant and verified information on coronavirus, patient counseling (including non-pharmacological measures and the recommendations on OTC drugs, dietary supplements), medication review on patient's request (screening for potentially significant drug-drug interactions, contraindications and precautions), health promotion and referral to a physician. Besides telepharmacy service, pharmacists were asked to document issues discussed with the patients/users, after obtaining their verbal permission. The chart for obtaining users' data in- The data were entered into Microsoft Office Excel document. Descriptive and statistical analysis was performed using IBM SPSS Statistics software (ver. 22). To describe the newly introduced remote service, the required sample size was calculated to 69 patients (confidence level 90%; margins of error 10%; population size 20,000+). The results of the descriptive analysis are presented as mean ± standard deviation (S.D.) for quantitative variables or frequency (number of patients/users n, %) for categorical variables. The difference in proportions between users aged <65 and ≥65 years was tested using the Chi-square test for independence or Fisher's exact test, where appropriate. The difference in quantitative variables between the two groups was analyzed using Student's t test. A p-value <0.05 was considered statistically significant. A total of 10 pharmacists from 7 community pharmacies accepted to participate voluntarily in the telepharmacy service. Data were collected for 71 patients/users from April 13, 2020, up to May 21, Demographic and clinical characteristics are presented in Table 1 . Telepharmacy users were on average 61.31 ± 13.27 years of age, with almost the equal share for adults (aged <65; 35, 49.3%) and elderly persons (≥65 years; 36, 50.7%). The difference in gender distribution was statistically significant-women were more prevalent among adults (almost 63%), whereas men were more prevalent in the elderly population (almost 61%) (p-value 0.043, Pearson Chisquare 4.079). Patients with chronic and/or acute/subacute conditions were predominant with a share of 84.5% (60 patients). Chronic diseases were the main reason for searching pharmacists' consultation (53 patients, 74.6%), out of which 5 patients (7%) had a complaint about worsening of a chronic condition, whereas 7 patients (9.9%) had only acute/subacute conditions (duration up to one month). There were 11 only users (15.5%), asking for information about coronavirus or COVID-19 (and not reporting any other health condition), which was noted as the main reason for calling. The main reasons for consultation with pharmacists, presented by organ systems, are summarised in Table 2 . Cardiovascular disease was the most frequent topic (12, 16.9%), followed by the musculoskeletal system (11, 15.5%) and central nervous system (7, 9.9%), with no significant difference in frequency between adults and elderly patients. Remote pharmaceutical care was provided for patients with a variety of diseases or conditions, involving 10 organ systems and with a total of 32 diseases/conditions listed (Table 2) . Information or counseling was provided on 48 different drugs, belonging to 12 anatomical therapeutic chemical (ATC) classification system groups, as presented in Table 3 . Telepharmacy users who did not have chronic or acute disease/condition were interested in relevant information on various aspects of COVID-19 pandemic: characteristics of the novel coronavirus; therapeutic options for COVID-19 treatment and their availability on the market; protective equipment (how to use masks, shields and gloves); proper use of disinfectants and ways to strengthen the immune system (dietary supplements, vitamins, minerals and non-pharmacological measures) ( Table 2) . Table 4 presents pharmacists' interventions resulting from the telepharmacy service. Drug shortages were a common concern among telepharmacy service users. The pharmacists provided information on drug shortages in 27 consultations (38%), raised as a primary or secondary issue during counseling. A total of 11 different drugs were involved in shortages-the most frequent was clonazepam (8 patients; 11.3%), ranked second were antineoplastics and immunomodulating agents (5, 7%; out of which tamoxifen in 3 patients, 4.2%; capecitabine 1, 1.4%; hydroxycarbamide 1, 1.4%), followed by (single dose, dosing interval and maximum daily dose), drug administration related to a meal, recommended therapy duration, and explanation of the mechanism of drug action and the time course for achieving a full therapeutic effect. Pharmacists also identified drug duplication, checked for contraindications or precautions, assessed potential clinically significant drug-drug interactions, but also tried to help patients who reported financial constraints with their chronic therapy. Three patients were reassured not to take prescription drugs on their own, as they require thorough assessment and prescribing by a doctor, and for the other three patients, mistakes in drug refill were found (1 prescription was missing per patient among their chronic therapy). To the best of our knowledge, this is the first study conducted in the European community pharmacy setting to assess the tel- . In our study, the proportion of telepharmacy service users' who required psychological support was calculated to 9.9%, whereas that percentage was quite higher in other studies, up to 33% (Meghana et al., 2021) . Besides applying their medication expertise, community pharmacists are expected to identify patients with excessive anxiety, concern, fear or blind optimism and provide psychological or emotional support . Pharmacist interventions presented in our study are in accordance with international results, proving the accessible position and important role of community pharmacists in providing continuing patient care (Kretchy et al., 2021; Zheng et al., 2021 (Cadogan & Hughes, 2021) . It is expected that pharmacists' involvement in this field could potentially reduce general physicians' ambulatory conditions-related workload by more than 50% (Paudyal et al., 2013) . Therefore, this set of telepharmacy services should be continued throughout the following pandemic period, with scheduling patients' follow-up and taking regular documentation of the pharmaceutical care process. On the other hand, a large proportion of chronic patients required counseling which could be completely performed via telephone. As presented in Table 4 , patients required support on adherence and lifestyle advice. Furthermore, the majority of drug-related issues were resolved by providing relevant information on drug safety and efficacy profile, accurate drug use, dosage, administration with or without meals, drug interactions, contraindications, precautions, therapy duration and avoiding drug duplication. A study by Ibrahim and colleagues also reported a higher proportion of drug-related interventions (range 4.03%-20.36%), provided by community pharmacists during telepharmacy services, which included change in medications due to potential drug-drug interactions or contraindications, removal of duplicate drugs, the addition of another medicine or modifying overdose (Ibrahim et al., 2020) . It is evident that the COVID-19 pandemic has driven the development of innovative and remote pharmacy services around the world since remote pharmacy services are strongly recommended to reduce human-to-human transmission (Liu et al., 2020; Zheng et al., 2021) . Moreover, Poudel and Nissen in 2016 have pointed that telepharmacy was becoming an integral part of modern pharmacy practice, improving the access to quality pharmaceutical services (Poudel & Nissen, 2016) . Besides its proven benefit for patients, legal challenges and requirements for the start-up of telepharmacy were marked as considerable pitfalls, such as time, effort and money (Poudel & Nissen, 2016) . Interestingly, the COVID-19 pandemic fosters the changes in pharmaceutical care services, surpassing all the anticipated barriers in implementing telepharmacy services. For instance, Spain reported an increase in the number of hospital pharmacy departments that offer telepharmacy programs including the delivery of medications from 17% before the crisis to 80% in the COVID-19 pandemic (Moreno & Gioia, 2020; Tortajada-Goitia et al., 2020) . This study had many limitations. The first is a small sample size, which does not allow us to draw firm conclusions regarding the telepharmacy service contribution to a gap in healthcare during the COVID-19 pandemic. Secondly, data were only collected from the centralised call number and may under-represent the calls fielded by pharmacists from patients that called their pharmacy directly. We did not assess pharmacists' attitudes or perceptions of telepharmacy, which could significantly impact the data collection. Moreover, we used an open-form patient's data chart to collect the data, where a pharmacist was expected to enter the patient's problem/query and the pharmacist's intervention provided to the patient. Therefore, Pharmacists' interventions and counseling aspects provided during telepharmacy service and specific needs and concerns, both COVID-and non-COVIDrelated, which should not be neglected. As the most accessible healthcare professionals, community pharmacists showed a high level of resilience and ability in addressing patients' needs, which may have short-and long-term beneficial effects on the health system (Mohamed Ibrahim et al., 2021; Visacri et al., 2021) . Apart from pharmacists' impact on controlling the spreading of infection by procurement and providing protective equipment (masks and hand gloves) and disinfectants to the local community, pharmacists are able to deliver telepharmacy services such as patient counseling, chronic disease management, patient monitoring, medication review and patients' referral to a specialist (Muflih et al., 2021 (Muflih et al., 2021) . The authors would like to thank pharmacists Ana Srdić, Anica Crkvenčić, Branka Keleč, Dušana Tanasić, Nataša Perućica Jazić, Nataša Milanović, Slavenka Borjanić, Vanja Đurđević, Vanja Ilić and Vanja Jošić for their participation. None declared. project administration (lead) and writing-review and editing (equal). The data that support the findings of this study are available from the corresponding author upon reasonable request. COVID-19 pandemic: Response plan by the Johns Hopkins Aramco Healthcare inpatient pharmacy department Resilience in the time of pandemic: The experience of community pharmacists during COVID-19 Pandemic preparedness of community pharmacies for COVID-19 Non-communicable disease management in vulnerable patients during Covid-19 On the frontline against COVID-19: Community pharmacists' contribution during a public health crisis Current practices and state regulations regarding telepharmacy in rural hospitals Chronic noncommunicable diseases: A sacrifice on the altar of COVID-19? Nonpharmaceutical measures for pandemic influenza in nonhealthcare settings-social distancing measures Community pharmacists: on the frontline of health service against COVID-19 in LMICs Role of telepharmacy in pharmacist counselling to coronavirus disease 2019 patients and medication dispensing errors Medication management and adherence during the COVID-19 pandemic: Perspectives and experiences from low-and middle-income countries Telepharmacy: A new paradigm for our profession Fighting against COVID-19: Innovative strategies for clinical pharmacists Providing pharmacy services during the coronavirus pandemic Treat all COVID 19-positive patients, but do not forget those negative with chronic diseases Emergency preparedness and response (EP&R) by pharmacy professionals in India: Lessons from the COVID-19 pandemic and the way forward The legal extension of the role of pharmacists in light of the COVID-19 global pandemic Evaluation of telepharmacy services in light of COVID-19 Telepharmacy. Ready for its global implementation? Farmacia Hospitalaria Pharmacists' experience, competence and perception of telepharmacy technology in response to COVID-19 Are pharmacy-based minor ailment schemes a substitute for other service providers? A systematic review Telepharmacy: A pharmacist's perspective on the clinical benefits and challenges Decision on the declaration of a state of emergency for the territory of the Republic of Srpska The Pharmaceutical Society of the Republic of Srpska Pharmacists are on the front line of COVID-19, but they need help too The positive pharmacy care law: An area-level analysis of the relationship between community pharmacy distribution, urbanity and social deprivation in England Survey on the situation of telepharmacy as applied to the outpatient care in hospital pharmacy departments in Spain during the COVID-19 pandemic Community pharmacist in public health emergencies: Quick to action against the coronavirus 2019-nCoV outbreak Impact of the COVID-19 pandemic on the core functions of primary care: Will the cure be worse than the disease? A qualitative interview study in Flemish GPs Role of pharmacist during the COVID-19 pandemic: A scoping review Telepharmacy: Time to pick up the line Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective Telepharmacy service experience during the COVID-19 pandemic in the Republic of Srpska